Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Biotron Ltd

BIT.AX ✓ COMPLIANT ☆ Track — members

ASX · Healthcare · Biotechnology & Medical Research ·

Australia Micro Cap Analyst: N/A

Last Close

$0.00

▼ -20.00%

Market Cap $3.99M · Vol 584.10K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$3.99M

Micro Cap

Div Yield

N/A

Semi-annual dividend

EPS Growth

N/A

YoY

RSI (14)

50.00

Momentum

Beta

0.34

vs Market

52W High

$0.00

56.25% below

52W Low

$0.00

34.61% above

Volume

584.10K

Avg 4.21M

P/B

4.81

Price-to-book

ROE

N/A

Return on equity

Free Float

70.98%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Biotron Ltd (BIT.AX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BIT.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.00%

-33.33%

YTD

-33.33%

-50.00%

-91.76%

-95.71%

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-209,619.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-43.23% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	4.81
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	2.79B

Technical Indicators

50-Day SMA	$0.00
200-Day SMA	$0.00
RSI (14)	50.00
Beta	0.34
52-Week High	$0.00
52-Week Low	$0.00

Volume Today	584.10K
Avg Daily Volume (30D)	4.21M
Relative Volume	0.14x
Volatility (10D)	157.79
Volatility (30D)	157.79
Free Float	70.98%

Analyst Consensus

N/A

Current Price $0.00

Mean Target N/A

52W Low$0.00 52W High$0.00

Current

Target

$0.00 $0.00

Current Analyst target

· 0 analysts

Identifiers

ExchangeASX

FIGIBBG001S5YKL0

ISINAU000000BIT4

CountryAustralia

Sub-IndustryBio Therapeutic Drugs

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

2359.HK WuXi AppTec Co Ltd -3.94% ARGX.BR argenx SE -4.19% ARGX argenx SE -2.76% INSM Insmed Inc -1.42% 2269.HK WuXi Biologics (Cayman) Inc -4.71%

Company Profile

Biotron Limited is a clinical-stage biotechnology company. The Company is engaged in developing and commercializing a novel small molecule approach that has the potential to treat several serious viral diseases. Its proprietary primary bacterial cell-based screening platform enables rapid screening for target viroporin proteins, including hepatitis C, HIV-1, Dengue, Zika, Influenza, and Respiratory Syncytial Virus (RSV). The Company has developed a library of over 350 compounds with potential activity against a range of viral diseases. Its lead compound, BIT225, is in Phase II development for the treatment of HIV-1. BIT225 appears to inhibit HIV-1 replication in macrophage reservoir cells offering the potential, when used in combination with other anti-retroviral compounds, to eradicate HIV-1. The Company also owns SedRx, which is a general anesthetic containing alfaxalone.